Metabolomics in toxicology: preclinical and clinical applications.
Applied and Investigative Metabolomics, Bristol-Myers Squibb Co., Princeton, New Jersey 08543, USA. don.robertson@bms.com
Donald G
DG
Robertson
Paul B
PB
Watkins
Michael D
MD
Reily
D000818:Animals; D015706:Bibliometrics; D015415:Biomarkers / Q000378:metabolism; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008658:Inactivation, Metabolic; D055432:Metabolomics / Q000379:methods*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D018675:Toxicity Tests; D014116:Toxicology / Q000379:methods*; D015262:Xenobiotics / Q000378:metabolism* / Q000633:toxicity
D015415:Biomarkers; D004364:Pharmaceutical Preparations; D015262:Xenobiotics